Key points are not available for this paper at this time.
In CUSTOMIZE, cabotegravir + rilpivirine LA was successfully implemented across a range of US healthcare settings. Barriers were mitigated with minor process adjustments.
Czarnogorski et al. (Thu,) studied this question.